ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Linius Technologies Limited

Linius Technologies Limited (LNU)

0.002
0.00
(0.00%)
Closed 05 October 4:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.002
Bid
0.001
Offer
0.002
Volume
880,350
0.002 Day's Range 0.002
0.001 52 Week Range 0.003
Market Cap
Previous Close
0.002
Open
0.002
Last Trade
96347
@
0.002
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
7,750,892
Shares Outstanding
5,546,740,714
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-0
Revenue
1.07M
Net Profit
-4.79M

About Linius Technologies Limited

Sector
Minrls,earths-ground,treated
Industry
Minrls,earths-ground,treated
Website
Headquarters
Melbourne, Victoria, Aus
Founded
-
Linius Technologies Limited is listed in the Minrls,earths-ground,treated sector of the Australian Stock Exchange with ticker LNU. The last closing price for Linius Technologies was AUD0. Over the last year, Linius Technologies shares have traded in a share price range of AUD 0.001 to AUD 0.003.

Linius Technologies currently has 5,546,740,714 shares in issue. The market capitalisation of Linius Technologies is AUD11.09 million. Linius Technologies has a price to earnings ratio (PE ratio) of 0.00.

LNU Latest News

Linius Partners with Hemisphere to Build Hyper-Personalized Advertising Prototype

New York, NY, March 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Linius Technologies Limited (ASX: LNU) – the only cloud-based solution that transforms static video into hyper-personalized...

Linius Successfully Tests World's First Virtual-Video Blockchain

•           Controls transaction of video assets within a blockchain •           Proves video blockchain is possible•           Delivers unique anti-piracy solution New York, NY, Feb. 21, 2019...

Former Netflix Director of Content Acquisition Joins Linius Advisory Board

New York, NY, Nov. 30, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Linius Technologies Limited (ASX: LNU) – the only cloud-based solution that transforms static video into hyper-personalized...

Linius Technologies to Showcase Company Growth at the 8th LD Micro Invitational

Linius Technologies Limited (ASX: LNU) (OTC: LNNTF), internet video virtualization technology pioneer, today announced that CEO Chris Richardson will present at the 8th annual LD Micro...

Director Shareholding

LENDU HOLDINGS PLC DIRECTORS' SHARE INTERESTS The Company has today been advised of the following changes of interest in the issued share capital by the directors of Lendu Holdings PLC as a...

Additional Listing

LENDU HOLDINGS PLC IRRIGATED-COTTON, BEEF-CATTLE AND CEREAL PRODUCTION IN QUEENSLAND AND NEW SOUTH WALES, AUSTRALIA The Company announces that it has applied to AIM for the admission of 24,067...

Holding(s) in Company

LENDU HOLDINGS PLC OWNERS AND OPERATORS OF IRRIGATED-COTTON, BEEF-CATTLE AND CEREAL FARMS, IN QUEENSLAND AND NEW SOUTH WALES, AUSTRALIA The Company has today been advised that El Oro Mining...

Final Results

LENDU HOLDINGS PLC OWNERS AND OPERATORS OF IRRIGATED-COTTON, BEEF-CATTLE AND CEREAL FARMS, COMPRISING 26,000 HECTARES, IN QUEENSLAND AND NEW SOUTH WALES, AUSTRALIA Announcement of unaudited...

Holding(s) in Company

LENDU HOLDINGS PLC OWNERS AND OPERATORS OF IRRIGATED-COTTON, BEEF-CATTLE AND CEREAL FARMS, IN QUEENSLAND AND NEW SOUTH WALES, AUSTRALIA The Company was advised on 27 August 2003 of the...

Holding(s) in Company

LENDU HOLDINGS PLC OWNERS AND OPERATORS OF IRRIGATED-COTTON, BEEF-CATTLE AND CEREAL FARMS, IN QUEENSLAND AND NEW SOUTH WALES, AUSTRALIA The Company has today been advised by Laxey Partners...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.0020.0020.0014337610.00171133DE
4000.0020.0030.00177508920.00199571DE
12000.0020.0030.00177508920.00199571DE
26000.0020.0030.00143605240.00194416DE
52000.0020.0030.00144789840.00199086DE
156-0.024-92.30769230770.0260.0280.00148390090.00559772DE
260-0.032-94.11764705880.0340.0750.00148491000.01783263DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
1TTThrive Tribe Technologies Ltd
AUD 0.002
(100.00%)
300k
OSLOOncoSil Medical Ltd
AUD 0.003
(50.00%)
82k
AZLOArizona Lithium Ltd
AUD 0.003
(50.00%)
1.01M
H2GGreenHy2 Ltd
AUD 0.006
(50.00%)
11.49M
ILAOIsland Pharmaceuticals Limited
AUD 0.059
(47.50%)
1.62M
ARVOCArtemis Resources Limited
AUD 0.001
(-50.00%)
250k
ASROAsra Minerals Ltd
AUD 0.001
(-50.00%)
8M
GENGenmin Limited
AUD 0.053
(-33.75%)
3.7M
EXTODExcite Technology Services Ltd
AUD 0.002
(-33.33%)
1.2M
ACWOCActinogen Medical Limited
AUD 0.007
(-30.00%)
258.07k
WCNWhite Cliff Minerals Limited
AUD 0.023
(9.52%)
111.74M
SYASayona Mining Limited
AUD 0.0305
(-4.69%)
55.11M
88E88 Energy Limited
AUD 0.002
(-20.00%)
38.58M
WCNOWhite Cliff Nickel
AUD 0.012
(33.33%)
33.36M
SIGSigma Healthcare Limited
AUD 2.055
(0.24%)
26.82M

Discussion

View Full Feed
Arnold25764 Arnold25764 4 minutes ago
Would be nice. See what next week brings.
DBGI
boston127 boston127 9 minutes ago
Not even Elon Musk could afford

to buy on every dip with this company. It is one nonstop long dip.
IGPK
Prominent Capital Prominent Capital 9 minutes ago
This might be huge:



AIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of Endometriosis

Source: GlobeNewswire Inc.

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the United States Pat
Dallas-Cowboys Dallas-Cowboys 10 minutes ago
Good for Nvidia

Data center finance leases
Buried within the footnote of its quarterly and annual reports, Microsoft lists the number of finance leases, mostly for data centers, that have yet to commence. The details include the amount of money it has contracted out for leases
NVDA
boston127 boston127 11 minutes ago
I'm hoping that you are correct.


- Has the company even applied for it?
- Why is the company so dull and not enthusiastically touting their accomplishments?
- Their website sucks and is outdated by a few years.
- We do not hear a word from them on anyth
LGHL
bbotcs bbotcs 17 minutes ago
lj: Florida weather
Thanks for the weather forecast video. A neighbor just cancelled her planned trip to Florida next week to visit her elderly mother.
bbotcs bbotcs 20 minutes ago
lj: re: interest rates
I think we are in a mild recession. When you don't see many cars at fast-food drive throughs, something is going on.
Egg prices are ridiculous. Eggs are in many food products. IMO, a big part of food inflation.
fuagf fuagf 24 minutes ago
In Mexico, ‘It’s Time for Women’

"Who is Claudia Sheinbaum? Here’s what to know about Mexico’s next president"

Claudia Sheinbaum took office on Tuesday as the country’s first female president.

By Catherine Osborn, the writer of Foreign Policy’s weekly Lat
bbotcs bbotcs 24 minutes ago
lj: Agree about the tax-loss selling this year. Not much out there to push up the market.
The election is a factor that should keep the market down for a month.
shajandr shajandr 26 minutes ago
https://www.gq.com/story/californias-vanishing-hippie-utopias
Horsts Horsts 28 minutes ago
😂😂😂😂🤡
WDLF
Hopeforthefuture3 Hopeforthefuture3 29 minutes ago
If merck want nwbo they still have time to make a purchase. They (MRK)may not think the market for gbm (dcvax plus keytruda) is large enough for them in terms of revenue especially until approved by fda. Should we get approval by MHRA merck may take an interest as then better chance for fda/usa appr
MRK
Horsts Horsts 31 minutes ago
Cool.
Does Shaun the Sheep and Epaz know this ?
Do they have that information ?
EPAZ
WesCrowe WesCrowe 35 minutes ago
Whats a reasonable Market Cap for 4 million in revenue. No debt. 9-10 million next year. Patents and no reverse split. &dvm traded up too 21,000 million with less revenue or similiar. I feel anywhere between 9-24 million is a reasonable area and range for Sinc.
SINC
Nrdc92 Nrdc92 41 minutes ago
There you go spinning nonsense again, Proto. Stephano Slack is a rinky-dink regional firm, wholly inappropriate for an alleged soon to be ubiquitous Nasdaq tech company. This proves again that LWLG is still playing in the minors, hoping one day to make it to the big leagues.

This is
LWLG
pepeoil pepeoil 46 minutes ago
The cult page wants an update from the receiver. If he did give one, it would be real simple. “Boys, you’re screwed”. Lol. Some clowns from the cult actually think the receiver is going to move the company forward. lol. Little do they know, he is unwinding it.
SHMP
toogoodfella toogoodfella 55 minutes ago
Re: still incoming from lawsuits?

Also, it says there will be a small group of administrator staff to remain and manage other litigations.

I EXPLAINED IT MANY TIMES

Check the cash flow. 210M is the only asset left to distribute. Ecaps money not included.
LEHNQ
AngeloFoca AngeloFoca 55 minutes ago
Merck could be sitting alone wondering what could have been.
It's exactly what I've been thinking... While we are all focused on Merck, it may well be someone we haven't even considered.



.
NWBO
Mr.Poole Mr.Poole 1 hour ago
ILUS leadership can’t merge into traffic much less merge companies. Heck can’t even change their name for how many years now. Got to hand it to them with dogged determination to the grift.
ILUS
toogoodfella toogoodfella 1 hour ago
RE: still incoming from lawsuits?

Nothing is coming other than ecaps money. Read the quarterly report. It says money from ecaps not included in the recovery.
LEHNQ
Mr.Poole Mr.Poole 1 hour ago
Shadyland scam just like BRYYF. His comical chart posts with that fictitious upward spike that never comes,
SDRC
fuagf fuagf 1 hour ago
Very nice. How did i miss it earlier, and how in hell did i get back
there just now. LOL It's a good view Jacy, of the two of you.
georgejjl georgejjl 1 hour ago
"...Cognision, providers of advanced neurobiomarker technology, announces its partnership with Anavex Life Sciences Corp. (Nasdaq: AVXL), in a phase 2 clinical trial of ANAVEX®3-71 in subjects with schizophrenia.

ANAVEX®3-71 is a therapeutic agent with a dual mecha
AVXL
fuagf fuagf 1 hour ago
Steve Schmidt is always good. "Decency is making a comeback in America" And that's a good thing.

Your Recent History

Delayed Upgrade Clock